APA

Poljakova J., Hrebackova J., Dvorakova M., Moserova M., Eckschlager T., Hrabeta J., Göttlicherova M., Kopejtkova B., Frei E., Kizek R. & Stiborova M. (20120412). Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma. : Neuro endocrinology letters.

Chicago

Poljakova Jitka, Hrebackova Jana, Dvorakova Marketa, Moserova Michaela, Eckschlager Tomas, Hrabeta Jan, Göttlicherova Marketa, Kopejtkova Barbora, Frei Eva, Kizek Rene and Stiborova Marie. 20120412. Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma. : Neuro endocrinology letters.

Harvard

Poljakova J., Hrebackova J., Dvorakova M., Moserova M., Eckschlager T., Hrabeta J., Göttlicherova M., Kopejtkova B., Frei E., Kizek R. and Stiborova M. (20120412). Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma. : Neuro endocrinology letters.

MLA

Poljakova Jitka, Hrebackova Jana, Dvorakova Marketa, Moserova Michaela, Eckschlager Tomas, Hrabeta Jan, Göttlicherova Marketa, Kopejtkova Barbora, Frei Eva, Kizek Rene and Stiborova Marie. Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma. : Neuro endocrinology letters. 20120412.